» Authors » R Rizzi

R Rizzi

Explore the profile of R Rizzi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 192
Citations 981
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Martino E, Palmieri S, Galli M, Derudas D, Mina R, Della Pepa R, et al.
ESMO Open . 2025 Jan; 10(2):104084. PMID: 39778329
Background: Daratumumab-refractory multiple myeloma (Dara-R MM) presents a significant treatment challenge. This study aimed to evaluate the efficacy and survival outcomes of elotuzumab, pomalidomide, and dexamethasone (EloPd) in a large,...
2.
3.
Giannico O, Baldacci S, Fragnelli G, Desiante F, Battista T, Calamai C, et al.
Ig Sanita Pubbl . 2022 Apr; 78(1):23-35. PMID: 35370294
Despite SARS-CoV-2 transmission being a complex phenomenon, greater population density seems to be a risk factor. The aim of this study was to analyze through an epidemiologic urban health approach...
4.
Baldacci S, Giannico O, Giorgino A, Buccoliero G, Desiante F, Fragnelli G, et al.
Ann Ig . 2020 Aug; 32(5):590-592. PMID: 32744589
No abstract available.
5.
Ronca A, Maiullari F, Milan M, Pace V, Gloria A, Rizzi R, et al.
Bioact Mater . 2018 May; 2(3):131-137. PMID: 29744422
The limited number of resins, available for stereolithography applications, is one of the key drivers in research applied to rapid prototyping. In this work an acrylic photocrosslinkable resin based on...
6.
Marei H, Hasan A, Rizzi R, Althani A, Afifi N, Cenciarelli C, et al.
Front Neurol . 2018 Feb; 9:34. PMID: 29467713
Ischemic stroke is one of the major health problems worldwide. The only FDA approved anti-thrombotic drug for acute ischemic stroke is the tissue plasminogen activator. Several studies have been devoted...
7.
Gusdorf L, Asli B, Barbarot S, Neel A, Masseau A, Puechal X, et al.
Allergy . 2016 Aug; 72(2):177-182. PMID: 27564982
Background: Schnitzler syndrome is characterized by an urticarial rash, a monoclonal gammopathy, and clinical, histological, and biological signs of neutrophil-mediated inflammation. The aim of this study was to assess the...
8.
Vannozzi L, Ricotti L, Cianchetti M, Bearzi C, Gargioli C, Rizzi R, et al.
Bioinspir Biomim . 2015 Aug; 10(5):056001. PMID: 26292037
This work aims to demonstrate the feasibility of a novel approach for the development of 3D self-assembled polydimethylsiloxane structures, to be used as engineered flexible matrices for bio-hybrid actuation. We...
9.
Brandes A, Franceschi E, Ermani M, Tosoni A, Albani F, Depenni R, et al.
Neurooncol Pract . 2015 Jun; 1(4):166-171. PMID: 26034628
Background: As yet, no population-based prospective studies have been conducted to investigate the incidence and clinical outcome of glioblastoma (GBM) or the diffusion and impact of the current standard therapeutic...
10.
Mele G, Melpignano A, Quarta G, Palumbo G, Capalbo S, Falcone A, et al.
Leuk Res . 2015 Feb; 39(3):279-83. PMID: 25636354
This current retrospective multicenter analysis represents, to our knowledge, the first Italian study evaluating the efficacy and toxicity profile of "lenalidomide plus dexamethasone" as salvage therapy in patients with recurrent-refractory...